Imaging of VSOP Labeled Stem Cells in Agarose Phantoms with Susceptibility Weighted and T2* Weighted MR Imaging at 3T: Determination of the Detection Limit

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Lobsien, Donald ^a   Dreyer, Antje Y ^b,c   Stroh, Albrecht ^d   Boltze, Johannes ^b,c,e   Hoffmann, Karl Titus ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VERY SMALL SUPERPARAMAGNETIC IRON OXIDE PARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL LABELING; CONTROLLED STUDY; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SHEEP; SUSCEPTIBILITY WEIGHTED IMAGING; T2 WEIGHTED IMAGING; THICKNESS;

ANIMALS; DISEASE MODELS, ANIMAL; FERRIC COMPOUNDS; LIMIT OF DETECTION; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STROMAL CELLS; PARTICLE SIZE; PHANTOMS, IMAGING; SEPHAROSE; SHEEP; STAINING AND LABELING; STEM CELL TRANSPLANTATION; STROKE;

EID: 84877269594     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062644     Document Type: Article

References (40)

1. Langhorne P, Bernhardt J, Kwakkel G, (2011) Stroke rehabilitation. Lancet 377(9778): 1693-702.
2. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, et al. (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375(9727): 1695-703.
3. Carpenter CR, Keim SM, Milne WK, Meurer WJ, Barsan WG, et al. (2011) Thrombolytic therapy for acute ischemic stroke beyond three hours. The Journal of Emergency Medicine 40(1): 82-92.
4. Ringleb PA, Bousser MG, Ford G, Bath P, Brainin M, et al. (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc. Dis. 25(5): 457-507.
5. Burns TC, Verfaillie CM, Low WC, (2009) Stem cells for ischemic brain injury: a critical review. J. Comp. Neurol. 515(1): 125-44.
6. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, et al. (2007) Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 38(5): 1655-711.
7. Liu YP, Lang BT, Baskaya MK, Dempsey RJ, Vemuganti R, (2009) The potential of neural stem cells to repair stroke-induced brain damage. Acta Neuropathol. 117(5): 469-80.
8. Kalladka D, Muir KW, (2011) Stem cell therapy in stroke: designing clinical trials. Neurochem. Int. 59(3): 367-70.
9. England T, Martin P, Bath PMW, (2009) Stem cells for enhancing recovery after stroke: a review. Int J Stroke. 4(2): 101-10.
10. Daadi MM, Hu S, Klausner J, Li Z, Sofilos M, et al. (2012) Imaging Neural Stem Cell Graft-Induced Structural Repair in Stroke. Cell Transplant. Oct 3. [Epub ahead of print].
11. Liu W, Frank JA, (2009) Detection and quantification of magnetically labeled cells by cellular MRI. Eur J Radiol. 70(2): 258-64.
12. Mahmoudi M, Hosseinkhani H, Hosseinkhani M, Boutry S, Simchi A, et al. (2011) Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem. Rev. 111(2): 253-80.
13. Weissleder R, Cheng HC, Bogdanova A, Bogdanov Jr A, (1997) Magnetically labeled cells can be detected by MR imaging. Journal of Magnetic Resonance Imaging. 7(1): 258-63.
14. Wu S, Zhang L, Zhong J, Zhang Z, (2010) Dual contrast magnetic resonance imaging tracking of iron-labeled cells in vivo. Cytotherapy. 12(7): 859-69.
15. Cromer Berman SM, Walczak P, Bulte JWM, (2011) Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 3(4): 343-55.
16. Chen C-L, Zhang H, Ye Q, Hsieh W-Y, Hitchens TK, et al. (2011) A new nano-sized iron oxide particle with high sensitivity for cellular magnetic resonance imaging. Mol Imaging Biol. 2011 Oct 13(5): 825-39.
17. Stroh A, Zimmer C, Werner N, Gertz K, Weir K, et al. (2006) Tracking of systemically administered mononuclear cells in the ischemic brain by high-field magnetic resonance imaging. Neuroimage. 33(3): 886-97.
18. The STEPS Participants, (2008) Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): Bridging Basic and Clinical Science for Cellular and Neurogenic Factor Therapy in Treating Stroke. Stroke. 40(2): 510-5.
19. Boltze J, Förschler A, Nitzsche B, Waldmin D, Hoffmann A, et al. (2008) Permanent middle cerebral artery occlusion in sheep: a novel large animal model of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 28(12): 1951-64.
20. Denic A, Macura SI, Mishra P, Gamez JD, Rodriguez M, et al. (2011) MRI in rodent models of brain disorders. Neurotherapeutics. 8(1): 3-18.
21. Pillai DR, Heidemann RM, Kumar P, Shanbhag N, Lanz T, et al. (2011) Comprehensive small animal imaging strategies on a clinical 3T dedicated head MR-scanner; adapted methods and sequence protocols in CNS pathologies. PLoS ONE. 6(2): e16091.
22. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng Y-CN, (2008) Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1. American Journal of Neuroradiology. 30(1): 19-30.
23. Dai Y, Zeng M, Li R, Rao S, Chen C, et al. (2011) Improving detection of siderotic nodules in cirrhotic liver with a multi-breath-hold susceptibility-weighted imaging technique. J Magn Reson Imaging. 34(2): 318-25.
24. Sehgal V, Delproposto Z, Haacke EM, Tong KA, Wycliffe N, et al. (2005) Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging. 22(4): 439-50.
25. Eibofner F, Steidle G, Kehlbach R, Bantleon R, Schick F, (2010) Positive contrast imaging of iron oxide nanoparticles with susceptibility-weighted imaging. Magn Reson Med. 64(4): 1027-38.
26. Dreyer A, Stroh A, Poesel C, Findeisen M, von Geymueller T, et al. (2012) Frameless Stereotaxy in Sheep-Neurosurgical and Imaging Techniques for Translational Stroke Research. In: Balestrino M, editor. Advances in the Preclinical Study of Ischemic Stroke. 1 ed. 21-46.
27. Fleige G, Seeberger F, Laux D, Kresse M, Taupitz M, et al. (2002) In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking. Investigative radiology37 (9):: 482.
28. Stroh A, Zimmer C, Gutzeit C, Jakstadt M, Marschinke F, et al. (2004) Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radical Biology and Medicine. 36(8): 976-84.
29. Stroh A, Faber C, Neuberger T, Lorenz P, Sieland K, et al. (2005) In vivo detection limits of magnetically labeled embryonic stem cells in the rat brain using high-field (17.6 T) magnetic resonance imaging. Neuroimage. 24(3): 635-45.
30. Heymer A, Haddad D, Weber M, Gbureck U, Jakob PM,et al. (2008) Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair. Biomaterials. Apr 29(10): 1473-83.
31. Chavhan GB, Babyn PS, Thomas B, Shroff MM, Haacke EM, (2009) Principles, techniques, and applications of T2*-based MR imaging and its special applications. Radiographics. Sep-Oct 29(5): 1433-49.
32. Landis JR, Koch GG, (1977) The measurement of observer agreement for categorical data. Biometrics. 33(1): 159-74.
33. Taupitz M, Schnorr J, Abramjuk C, Wagner S, Pilgrimm H, et al. (2000) New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits. J Magn Reson Imaging. 12(6): 905-11.
34. Hoehn M, Küstermann E, Blunk J, Wiedermann D, Trapp T, et al. (2002) Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl. Acad. Sci. U.S.A. 99(25): 16267-72.
35. Jendelová P, Herynek V, DeCroos J, Glogarová K, Andersson B, et al. (2003) Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn Reson Med. 50(4): 767-76.
36. Magnitsky S, Watson DJ, Walton RM, Pickup S, Bulte JWM, et al. (2005) In vivo and ex vivo MRI detection of localized and disseminated neural stem cell grafts in the mouse brain. Neuroimage. Juli 1 26(3): 744-54.
37. Takahashi M, Uematsu H, Hatabu H, (2003) MR imaging at high magnetic fields. Eur J Radiol. 46(1): 45-52.
38. Mittal S, Wu Z, Neelavalli J, Haacke EM, (2008) Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2. American Journal of Neuroradiology. 30(2): 232-52.
39. Deistung A, Mentzel H-J, Rauscher A, Witoszynskyj S, Kaiser WA, et al. (2006) Demonstration of paramagnetic and diamagnetic cerebral lesions by using susceptibility weighted phase imaging (SWI). Z Med Phys. 16(4): 261-7.
40. Burns TC, Steinberg GK, (2011) Stem cells and stroke: opportunities, challenges and strategies. Expert Opin Biol Ther. Apr 11(4): 447-61.